190 related articles for article (PubMed ID: 17627607)
21. Elucidating the Impact of Payload Conjugation on the Cell-Penetrating Efficiency of the Endosomal Escape Peptide dfTAT: Implications for Future Designs for CPP-Based Delivery Systems.
Diaz J; Pietsch M; Davila M; Jaimes G; Hudson A; Pellois JP
Bioconjug Chem; 2023 Oct; 34(10):1861-1872. PubMed ID: 37774419
[TBL] [Abstract][Full Text] [Related]
22. Anti-Inflammatory Effects of Synthetic Peptides Based on Glucocorticoid-Induced Leucine Zipper (GILZ) Protein for the Treatment of Inflammatory Bowel Diseases (IBDs).
Paglialunga M; Flamini S; Contini R; Febo M; Ricci E; Ronchetti S; Bereshchenko O; Migliorati G; Riccardi C; Bruscoli S
Cells; 2023 Sep; 12(18):. PubMed ID: 37759516
[TBL] [Abstract][Full Text] [Related]
23. Ubiquitin Engineering for Interrogating the Ubiquitin-Proteasome System and Novel Therapeutic Strategies.
Tang JQ; Marchand MM; Veggiani G
Cells; 2023 Aug; 12(16):. PubMed ID: 37626927
[TBL] [Abstract][Full Text] [Related]
24. Pharmacokinetics, biodistribution and toxicology of novel cell-penetrating peptides.
Reveret L; Leclerc M; Morin F; Émond V; Calon F
Sci Rep; 2023 Jul; 13(1):11081. PubMed ID: 37422520
[TBL] [Abstract][Full Text] [Related]
25. In vitro selection of macrocyclic peptide inhibitors containing cyclic γ
Miura T; Malla TR; Owen CD; Tumber A; Brewitz L; McDonough MA; Salah E; Terasaka N; Katoh T; Lukacik P; Strain-Damerell C; Mikolajek H; Walsh MA; Kawamura A; Schofield CJ; Suga H
Nat Chem; 2023 Jul; 15(7):998-1005. PubMed ID: 37217786
[TBL] [Abstract][Full Text] [Related]
26. Extracellular Vesicles, Cell-Penetrating Peptides and miRNAs as Future Novel Therapeutic Interventions for Parkinson's and Alzheimer's Disease.
Keighron CN; Avazzadeh S; Goljanek-Whysall K; McDonagh B; Howard L; Ritter T; Quinlan LR
Biomedicines; 2023 Feb; 11(3):. PubMed ID: 36979707
[TBL] [Abstract][Full Text] [Related]
27. Transportan 10 Induces Perturbation and Pores Formation in Giant Plasma Membrane Vesicles Derived from Cancer Liver Cells.
Anselmo S; Sancataldo G; Baiamonte C; Pizzolanti G; Vetri V
Biomolecules; 2023 Mar; 13(3):. PubMed ID: 36979427
[TBL] [Abstract][Full Text] [Related]
28. Strategies to target the cancer driver MYC in tumor cells.
Weber LI; Hartl M
Front Oncol; 2023; 13():1142111. PubMed ID: 36969025
[TBL] [Abstract][Full Text] [Related]
29. Delivery of Active AKT1 to Human Cells.
Siddika T; Balasuriya N; Frederick MI; Rozik P; Heinemann IU; O'Donoghue P
Cells; 2022 Nov; 11(23):. PubMed ID: 36497091
[TBL] [Abstract][Full Text] [Related]
30. Antimicrobial Activity of Peptide-Coupled Antisense Peptide Nucleic Acids in Streptococcus pneumoniae.
Barkowsky G; Abt C; Pöhner I; Bieda A; Hammerschmidt S; Jacob A; Kreikemeyer B; Patenge N
Microbiol Spectr; 2022 Dec; 10(6):e0049722. PubMed ID: 36321914
[TBL] [Abstract][Full Text] [Related]
31. Thyclotides, tetrahydrofuran-modified peptide nucleic acids that efficiently penetrate cells and inhibit microRNA-21.
Clausse V; Zheng H; Amarasekara H; Kruhlak M; Appella DH
Nucleic Acids Res; 2022 Oct; 50(19):10839-10856. PubMed ID: 36215040
[TBL] [Abstract][Full Text] [Related]
32. Peptides as Pharmacological Carriers to the Brain: Promises, Shortcomings and Challenges.
Parrasia S; Szabò I; Zoratti M; Biasutto L
Mol Pharm; 2022 Nov; 19(11):3700-3729. PubMed ID: 36174227
[TBL] [Abstract][Full Text] [Related]
33. Highway to Cell: Selection of the Best Cell-Penetrating Peptide to Internalize the CFTR-Stabilizing iCAL36 Peptide.
Seisel Q; Lakumpa I; Josse E; Vivès E; Varilh J; Taulan-Cadars M; Boisguérin P
Pharmaceutics; 2022 Apr; 14(4):. PubMed ID: 35456644
[TBL] [Abstract][Full Text] [Related]
34. Peptide-based delivery of therapeutics in cancer treatment.
Samec T; Boulos J; Gilmore S; Hazelton A; Alexander-Bryant A
Mater Today Bio; 2022 Mar; 14():100248. PubMed ID: 35434595
[TBL] [Abstract][Full Text] [Related]
35. How Cargo Identity Alters the Uptake of Cell-Penetrating Peptide (CPP)/Cargo Complexes: A Study on the Effect of Net Cargo Charge and Length.
Hymel HC; Rahnama A; Sanchez OM; Liu D; Gauthier TJ; Melvin AT
Cells; 2022 Apr; 11(7):. PubMed ID: 35406759
[TBL] [Abstract][Full Text] [Related]
36. Effect of hydrophobic moment on membrane interaction and cell penetration of apolipoprotein E-derived arginine-rich amphipathic α-helical peptides.
Takechi-Haraya Y; Ohgita T; Kotani M; Kono H; Saito C; Tamagaki-Asahina H; Nishitsuji K; Uchimura K; Sato T; Kawano R; Sakai-Kato K; Izutsu KI; Saito H
Sci Rep; 2022 Mar; 12(1):4959. PubMed ID: 35322082
[TBL] [Abstract][Full Text] [Related]
37. Polycondensed Peptide Carriers Modified with Cyclic RGD Ligand for Targeted Suicide Gene Delivery to Uterine Fibroid Cells.
Egorova A; Shtykalova S; Maretina M; Selutin A; Shved N; Deviatkin D; Selkov S; Baranov V; Kiselev A
Int J Mol Sci; 2022 Jan; 23(3):. PubMed ID: 35163086
[TBL] [Abstract][Full Text] [Related]
38. Novel Lysine-Rich Delivery Peptides of Plant Origin ERD and Human S100: The Effect of Carboxyfluorescein Conjugation, Influence of Aromatic and Proline Residues, Cellular Internalization, and Penetration Ability.
Sebák F; Horváth LB; Kovács D; Szolomájer J; Tóth GK; Babiczky Á; Bősze S; Bodor A
ACS Omega; 2021 Dec; 6(50):34470-34484. PubMed ID: 34963932
[TBL] [Abstract][Full Text] [Related]
39. Cell-penetrating peptides improve pharmacokinetics and pharmacodynamics of anticancer drugs.
Rusiecka I; Gągało I; Kocić I
Tissue Barriers; 2022 Jan; 10(1):1965418. PubMed ID: 34402743
[TBL] [Abstract][Full Text] [Related]
40. Cell-Penetrating Peptides and Transportan.
Langel Ü
Pharmaceutics; 2021 Jun; 13(7):. PubMed ID: 34210007
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
